A BILLION CURIES AND COUNTING: 50 YEARS OF CANADIAN NUCLEAR INNOVATION IN HEALTHCARE
36th Annual CNS Conference - 2016 June 19-22


Presented at:
36th Annual CNS Conference
2016 June 19-22
Location:
Toronto, Canada
Session Title:
Plenary 2A: Innovation in Health and Nuclear Medicine

Authors:
J. Grozelle (Nordion Inc.)
  

Abstract

This collaborative project by GA, MURR, and Nordion utilizes a transformational radioisotope production system to produce the medical isotope Molybdenum-99 (Mo-99) by utilizing existing nuclear infrastructure located in the United States and Canada. The project uses innovative, reusable low enriched uranium (LEU) irradiation targets and integrated gaseous extraction system to generate and selectively remove Mo-99 suitable for use in all existing Tc-99m generators.

The Selective Gas Extraction (SGE) targets will be installed in the MURR reactor reflector region where they receive neutrons from the reactor to produce Mo-99. The targets are designed to allow selective reaction of Mo-99 with a suitable extraction gas during the irradiation process. Mo-99 is mobilized as a gas, which is transferred outside the reactor for collection at MURR and purification at Nordion's existing cGMP facility in Ottawa. SGE technology maximizes isotope production while minimizing the amount of LEU needed.

Individual Conference-Paper Copies (Electronic Where Available):

  • For CNS members, the first 5 copies per calendar year are free, and additional copies are $10 each.
  • For non-members, the price is $25 for the first Conference-paper copy in a request, and $10 each for additional copies of papers in the same conference and in the same request.
  • Contact the CNS office to order reprints.